Global Strategic Management »

GlaxoSmithKline shares owned by Global Strategic Management

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by Global Strategic Management from 13F filings

Historical chart of Global Strategic Management investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by Global Strategic Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by Global Strategic Management

Quarter filed Position value Share count Share price at filing
2020-12-31 $500k 14k 36.79

More positions owned by Global Strategic Management

Franco-Nevada Corporation (FNV)
Metalla Rty & Streaming Com New (MTA)
Osisko Gold Royalties (OR)
Fortuna Silver Mines Call Option (FSM)
E M X Royalty Corpor small blend (EMX)
Royal Gold (RGLD)
Barrick Gold Corp Call Option (GOLD)
Pan American Silver Corp Can Call Option (PAAS)
Ares Capital Corporation (ARCC)
Vista Gold Corp Com New (VGZ)
Wheaton Precious Metals Corp (WPM)
Agnico (AEM)
Gladstone Investment Corporation (GAIN)
Pretium Res Inc Com Isin# Ca74
Barclays Bank Plc Ipth SR B S&P

View all positions for Global Strategic Management

Top funds holding GlaxoSmithKline

Kahn Brothers Group
Damian Sousa
Columbia Asset Management
Paradigm Asset Management Company
Accent Capital Management
Park Circle
Byrne Asset Management
Retirement Group
Huntington National Bank

View all funds holding GlaxoSmithKline